ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · IEX Real-Time Price · USD
16.31
-0.28 (-1.69%)
At close: Apr 25, 2024, 4:00 PM
16.35
+0.04 (0.25%)
After-hours: Apr 25, 2024, 7:55 PM EDT
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of $2.69 billion as of April 25, 2024. Its market cap has decreased by -16.00% in one year.
Market Cap
2.69B
Enterprise Value
2.29B
1-Year Change
-16.00%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from $112.80M to $2.69B, an increase of 2,282.47%. That is a compound annual growth rate of 17.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 2.73B | -0.90% |
Apr 23, 2024 | 2.76B | -1.47% |
Apr 22, 2024 | 2.80B | 1.01% |
Apr 19, 2024 | 2.77B | -1.46% |
Apr 18, 2024 | 2.81B | -0.70% |
Apr 17, 2024 | 2.83B | 0.64% |
Apr 16, 2024 | 2.81B | 1.12% |
Apr 15, 2024 | 2.78B | -1.46% |
Apr 12, 2024 | 2.82B | -1.55% |
Apr 11, 2024 | 2.87B | -1.80% |
Apr 10, 2024 | 2.92B | -2.31% |
Apr 9, 2024 | 2.99B | 1.97% |
Apr 8, 2024 | 2.93B | -1.17% |
Apr 5, 2024 | 2.97B | -0.22% |
Apr 4, 2024 | 2.97B | -2.01% |
Apr 3, 2024 | 3.04B | 1.71% |
Apr 2, 2024 | 2.98B | -0.82% |
Apr 1, 2024 | 3.01B | -1.24% |
Mar 28, 2024 | 3.05B | 1.59% |
Mar 27, 2024 | 3.00B | 2.30% |
Mar 26, 2024 | 2.93B | -0.28% |
Mar 25, 2024 | 2.94B | -0.61% |
Mar 22, 2024 | 2.96B | -2.50% |
Mar 21, 2024 | 3.03B | -1.34% |
Mar 20, 2024 | 3.07B | -0.21% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HUTCHMED (China) | 2.95B |
LivaNova | 2.91B |
Azenta | 2.84B |
TransMedics Group | 2.83B |
IDEAYA Biosciences | 2.80B |
Apogee Therapeutics | 2.79B |
Immunocore Holdings | 2.78B |
Arcellx | 2.75B |